Geron
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Geron and other ETFs, options, and stocks.About GERN
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies.
CEOHarout Semerjian
CEOHarout Semerjian
Employees229
Employees229
HeadquartersFoster City, California
HeadquartersFoster City, California
Founded1990
Founded1990
Employees229
Employees229
GERN Key Statistics
Market cap721.34M
Market cap721.34M
Price-Earnings ratio-9.32
Price-Earnings ratio-9.32
Dividend yield—
Dividend yield—
Average volume11.19M
Average volume11.19M
High today$1.15
High today$1.15
Low today$1.11
Low today$1.11
Open price$1.12
Open price$1.12
Volume3.10M
Volume3.10M
52 Week high$4.21
52 Week high$4.21
52 Week low$1.04
52 Week low$1.04
Stock Snapshot
The current Geron(GERN) stock price is $1.13, with a market capitalization of 721.34M. The stock trades at a price-to-earnings (P/E) ratio of -9.32.
On 2025-11-17, Geron(GERN) stock moved within a range of $1.11 to $1.15. With shares now at $1.13, the stock is trading +1.8% above its intraday low and -1.7% below the session's peak.
Trading volume for Geron(GERN) stock has reached 3.1M, versus its average volume of 11.19M.
Over the past 52 weeks, Geron(GERN) stock has traded between a high of $4.21 and a low of $1.04.
Over the past 52 weeks, Geron(GERN) stock has traded between a high of $4.21 and a low of $1.04.
Analyst ratings
67%
of 6 ratingsBuy
66.7%
Hold
16.7%
Sell
16.7%
People also own
Based on the portfolios of people who own GERN. This list is generated using Robinhood data, and it’s not a recommendation.